Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OUTLAST-B: Buprenorphine for Opioid Use Disorder Treatment Linkage
NCT04991974Phase 3Completed
- Sponsor
- Friends Research Institute
- Start
- Sep 2021
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of v1003 in opioid use disorder (OUD), sponsored by Friends Research Institute. Started Sep 2021; status: completed.
02
Drugs
v1003
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04991974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04991974.